首页> 美国卫生研究院文献>Bioscience Reports >Investigation of ICOS CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
【2h】

Investigation of ICOS CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population

机译:患有肝细胞癌的ICOSCD28和CD80基因多态性调查:病例对照研究在中国东部人群中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T>C, rs10932029 T>C, CD28 rs3116496 T>C and CD80 rs7628626 C>A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T>C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T>C, CD28 rs3116496 T>C and CD80 rs7628626 C>A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T>C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T>C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T>C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.
机译:免疫相关基因中的单核苷酸多态性(SNP)可能影响癌症的易感性。我们选择了诱导性T细胞共刺激物(ICOS)rs4404254 T> C,rs10932029 T> C,CD28 rs3116496 T> C和CD80 rs7628626 C> A SNP,并评估了这些SNP与肝细胞癌(HCC)风险的潜在关系。总共招募了584例HCC病例和923例健康对照。然后使用SNPscan™基因分型法获得ICOS,CD28和CD80多态性的基因型。我们发现ICOS rs10932029 T> C多态性显着增加了HCC的风险(加性模型:校正后的优势比(OR)为1.59; 95%置信区间(CI)为1.13–2.22; P = 0.007;纯合子模型:校正后的OR, 1.12; 95%CI,0.31-4.03; P = 0.867;优势模型:调整后的OR,1.58; 95%CI,1.14-2.19; P = 0.007和隐性模型:调整后的OR,1.02; 95%CI,0.28-3.68; P = 0.974)。但是,ICOS rs4404254 T> C,CD28 rs3116496 T> C和CD80 rs7628626 C> A SNP与肝癌风险无关。为了评估ICOS rs10932029 T> C对不同年龄,性别,慢性乙型肝炎病毒(HBV)感染,吸烟和饮酒状况的影响,对HCC风险的影响,我们进行了分层分析。我们发现,ICOS rs10932029 T> C多态性可能增加男性,≥53岁,从不吸烟,从不饮酒和非慢性HBV感染亚组的HCC风险。我们的研究突出表明,ICOS rs10932029 T> C多态性可能赋予肝癌易感性。探索免疫相关基因的变异与肝癌的发展之间的关系可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号